top of page

Early Mistakes That Create NDA/BLA Preparation Pain Later

  • Feb 25
  • 2 min read

Why NDA/BLA Pain Rarely Starts at Submission

The NDA/BLA Process, a SWOT blog series. Image: A woman with a flag climbing to the top of a mountain with milestone points along the way.

When NDA or BLA preparation becomes painful, it’s tempting to blame timelines, FDA questions, or late-breaking issues. In reality, most submission pain has much deeper roots. 

The majority of problems we see during NDA/BLA preparation trace back to early, well-intentioned decisions made when teams were focused—appropriately—on speed and survival. 


These mistakes are rarely obvious at the time. They accumulate quietly and surface only when the submission forces everything into a single, defensible story.


Mistake #1: Treating IND Success as Proof Systems Will Scale

Running an IND successfully is a real achievement, but IND success does not automatically mean your processes will scale to NDA/BLA volume. IND submissions are episodic. NDA/BLA work is sustained, concurrent, and far more interconnected. Teams often discover too late that what worked for INDs becomes fragile when document counts explode and timelines overlap.


Smart Solution #1: Pressure Test Early

Pressure-test IND-era processes during Phase 2–3 by modeling NDA/BLA-level volume and concurrency. Identifying strain points early allows teams to adjust capacity and workflows before timelines become inflexible.


Mistake #2: Reconstructing Decisions Instead of Capturing Them

Early-stage teams make smart tradeoffs every day—but often fail to document why those choices were made. By the time NDA/BLA preparation begins, original context may be lost, staff may have changed, and assumptions may no longer be obvious. Reconstructing rationale under pressure is one of the biggest drivers of late-stage stress and inefficiency.


Smart Solution #2: Document as You Go

Capture decision rationale in real time, even at a high level. A lightweight record of the “why” behind key choices can prevent weeks of retrospective reconstruction during submission preparation.


Mistake #3: Letting Functions Drift Out of Alignment Prior to NDA/BLA Preparation

Clinical, CMC, regulatory, and quality teams often move at different speeds early on. Without intentional alignment, small disconnects compound into major inconsistencies across submission modules. NDA/BLA review exposes misalignment quickly—and publicly.


Smart Solution #3: Schedule Cross-Functional Check-Ins

Introduce regular cross-functional check-ins focused specifically on downstream NDA/BLA impact, not just near-term deliverables. Early alignment reduces rework and defensibility risk later.


Mistake #4: Underestimating Submission Volume and Concurrency

NDA/BLA preparation introduces multiple modules, rolling amendments, labeling iterations, and frequent updates. Many first-time sponsors underestimate just how much work happens in parallel. This is where personnel capacity—not tools—becomes the limiting factor.


Smart Solution #4: Plan for Peaks, not Valleys

Plan for peak workload, not average workload. Early capacity planning—whether through staffing, outsourcing, or hybrid support—helps prevent burnout and missed timelines during critical submission windows.


Avoiding These Mistakes Without Slowing Down

Avoiding NDA/BLA pain doesn’t require heavy process or bureaucracy. It requires awareness, light documentation of rationale, and honest capacity planning. Small adjustments early can prevent major disruption later. 


Want an objective analysis of your NDA/BLA readiness? SWOT can help! With decades of experience in regulatory operations at all stages, we know how to help you create a roadmap that sets your company up for success. Reach out and let us know how we can support your team.


Looking Ahead

In the next post in our yearlong NDA/BLA series, we’ll explore how Phase 3 trial design choices directly affect NDA/BLA defensibility. Understanding this connection early can significantly reduce regulatory risk.



bottom of page